Financials
- Market Capitalization 3.49 B
- Employee 3 009
- Founded 1971
- CEO Christopher Simon
- Website www.haemonetics.com
- Headquarter Massachusetts, United States
- FIGI BBG000C7TF41
- Industry Medical Instruments & Supplies
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1450 | NVST Envista Holdings Corporation Common Stock | 26.21 USD | +1.16% | -5.52% | +3.31% | +27.11% | 4.27 B USD | ||
| 1512 | ICUI ICU Medical, Inc. - Common Stock | 157.60 USD | +2.06% | -1.64% | +9.21% | +27.42% | 3.94 B USD | ||
| 1620 | WRBY Warby Parker Inc. Class A Common Stock | 27.42 USD | -5.61% | -7.05% | +0.51% | +18.44% | 3.36 B USD | ||
| 1835 | XRAY DENTSPLY SIRONA Inc. - Common Stock | 12.78 USD | +4.24% | +2.73% | +24.44% | -3.03% | 2.56 B USD |
Frequently asked questions about Haemonetics Corporation Common Stock
What is the Haemonetics Corporation Common Stock stock price today?
The current price of Haemonetics Corporation Common Stock (HAE) is 76.86. Over the past 24 hours, the stock has changed by +0.85%. Follow the HAE chart for real-time price dynamics.
What is the stock ticker of Haemonetics Corporation Common Stock?
Haemonetics Corporation Common Stock trades under the ticker HAE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Haemonetics Corporation Common Stock stock going up?
HAE has changed by +0.47% over the last week, -1.89% over the last month, and +50.35% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Haemonetics Corporation Common Stock net income for the last quarter?
Haemonetics Corporation Common Stock reported net income of -20.15 M for the last quarter. The previous quarter showed 44.74 M, which means net income changed by -145.03%.
How many employees does Haemonetics Corporation Common Stock have?
As of the latest available data, Haemonetics Corporation Common Stock has 3 009 employees. Workforce size can provide additional context about the company's scale and operations.
What is Haemonetics Corporation Common Stock EBITDA?
Haemonetics Corporation Common Stock EBITDA is 42.88 M, and its EBITDA margin is 12.38%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Haemonetics Corporation Common Stock stock?
You can buy Haemonetics Corporation Common Stock (HAE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Haemonetics Corporation Common Stock stock?
Investing in Haemonetics Corporation Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HAE chart and related analysis on metatrader.com as part of your research.